Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 7/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16622846 | 0.87 | NPC1 (0.55) | NPC1MAPTKMT2AGAARAB9A | |
| SCHEMBL6121152 | 0.85 | NPC1 (0.57) | NPC1MAPTKMT2ARAB9AL3MBTL1 | |
| SCHEMBL30073645 | 0.82 | NPC1 (0.65) | NPC1MAPTKMT2AGAARAB9A | |
| SCHEMBL3456146 | 0.82 | NPC1 (0.65) | NPC1MAPTKMT2AGAARAB9A | |
| SCHEMBL3954720 | 0.82 | NPC1 (0.65) | NPC1MAPTKMT2AGAARAB9A | |
| SCHEMBL2751444 | 0.81 | DRD4 (0.64) | NPC1MAPTKMT2AGAARAB9A | |
| SCHEMBL29818792 | 0.80 | NPC1 (0.62) | NPC1MAPTRAB9AL3MBTL1HPGD | |
| SCHEMBL7928067 | 0.80 | NPC1 (0.62) | NPC1MAPTRAB9AL3MBTL1HPGD | |
| SCHEMBL2753551 | 0.78 | DRD4 (0.64) | NPC1MAPTRAB9AL3MBTL1EPHX1 | |
| SCHEMBL435720 | 0.77 | KMT2A (0.69) | NPC1MAPTKMT2AGAARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9882136-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2018-01-30 | — | — | US | disclosed |
| EP-2858458-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2017-05-31 | — | — | EP | disclosed |
| US-20150287920-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| EP-2858458-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2015-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150287920-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | CDH1, STRA6, SLC39A7 | NPC1 1060/4885MAPT 490/4885KMT2A 3759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.